Panaji Journal

Biostimulants Market Projected to Garner Significant Revenues by 2025

 Breaking News
  • No posts were found

Biostimulants Market Projected to Garner Significant Revenues by 2025

March 20
22:36 2020
Biostimulants Market Projected to Garner Significant Revenues by 2025

MarketsandMarkets™
The biostimulants market is estimated to account for USD 2.6 billion in 2019 and is projected to reach USD 4.9 billion by 2025, at a CAGR of 11.24% during the forecast period.

The report Biostimulants Market by Active Ingredient (Humic Substances, Amino Acids, Seaweed Extracts, Microbial Amendments), Crop Type (Fruits & Vegetables, Cereals, Turf & Ornamentals), Application Method, Form, and Region – Global Forecast to 2025″, The market for biostimulants is projected to reach USD 4.9 billion by 2025, at a CAGR of 11.24% during the forecast period. It is driven by seaweed extract-based biostimulants, abundant growth in seaweed cultivation near major biostimulant markets, and rise in their adoption by key players in biostimulant formulations.

Biostimulants Market

The increasing awareness of nutritional benefits associated with biostimulants and their application on broad-acre crops have widened the scope of growth within the biostimulants market.

The usage of biostimulants has evolved immensely from high-value crops such as fruits & vegetables to broad-acre crops such as cereals, pulses, and fiber crops. It has been observed that biostimulants enhance the uptake of nutrients, develop tolerance to abiotic stresses, and increase the vigor and yield of crops such as wheat, rice, and barley. The immense possibility in the application of biostimulants for these broad-acre crops can lead to the significant growth of this market. Many domestic manufacturers have begun to realize the prospective demand in the coming years, with several launches targeted on crops such as rice, corn, and wheat.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1081

On the basis of form, the liquid segment is projected to witness higher growth in the biostimulants market.

Various factors, such as the type of crop, type of storage available, size of the field, and weather conditions in the region, are attributable to the selection of the form, in which, biostimulants ought to be used. Most biostimulants are available in the liquid form. However, dry soluble formulations are also being made available, owing to their ease of handling and increased shelf life. Suspension concentrate formulations are the most commonly available liquid form of biostimulants. Major companies that manufacture liquid-based biostimulants include Ilsa (acquired by Italy-based Biolchim), UPL (US), Koppert (Netherlands), BioAg Alliance [Monsanto (US), and Novozymes (Denmark).

With the introduction of stringent regulations, Europe is estimated to dominate the biostimulants market in 2019.

The biostimulants market in Europe is driven by the adoption of modern agricultural technology such as precision farming, plant biotechnology, and organic-based active ingredients. The increasing awareness of consumers about the benefits of biostimulants is expected to contribute to market growth. Moreover, the European legislation is in the process of recognizing biostimulants as important plant nutrition, and have paved the way toward a regulated environment for these products. Moreover, biostimulant products were initially applied only on high-value crops such as fruits and vegetables in Europe. However, the industrial importance has transformed some broad-acre crops such as corn and wheat into high-value crops, resulting in the increased use of biostimulants for these crops.

This report includes a study of the development strategies of leading companies. The scope of this report includes a detailed study of biostimulant manufacturers such as BASF (Germany), Isagro (Italy), Valagro (Italy), Bayer (Germany), Italpollina (Italy), and UPL (India).

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=1081

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Media Contact
Company Name: MarketsandMarkets
Contact Person: Mr. Sanjay Gupta
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/biostimulant-market-1081.html

Related Articles